MercoPress, en Español

Montevideo, April 24th 2024 - 23:04 UTC

Tag: cancer

  • Tuesday, October 2nd 2018 - 08:43 UTC

    Nobel Medicine Prize for harnessing immune system to fight cancer

    “Allison and Honjo showed how different strategies for inhibiting the brakes on the immune system can be used in the treatment of cancer”

    James Allison from the United States and Japanese Tasuku Honjo won the 2018 Nobel Prize for Medicine for discoveries leading to new approaches in harnessing the immune system to fight cancer, the award-giving body said on Monday.

  • Monday, October 1st 2018 - 08:47 UTC

    WHO kicks off global initiative to treat children with cancer

    Cancer is a leading cause of death for children, with 300 000 new cases diagnosed each year among children aged 0-19 years

    WHO has announced a new effort - the WHO Global Initiative for Childhood Cancer - with the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives. This new target represents a doubling of the global cure rate for children with cancer.

  • Thursday, September 13th 2018 - 10:29 UTC

    Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018

    One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease

    The International Agency for Research on Cancer (IARC) released on Wednesday the latest estimates on the global burden of cancer. The GLOBOCAN 2018 database, accessible online as part of the IARC Global Cancer Observatory, provides estimates of incidence and mortality in 185 countries for 36 types of cancer and for all cancer sites combined. An analysis of these results, published today in CA: A Cancer Journal for Clinicians, highlights the large geographical diversity in cancer occurrence and the variations in the magnitude and profile of the disease between and within world regions.

  • Friday, August 24th 2018 - 08:16 UTC

    Monsanto glyphosate weed killer could cost Bayer billions in damage lawsuits

    Bayer said the number of outstanding cases had risen from 5,200 to 8,000. The company's shares are down 11% since it lost the case in a California court

    United States agro-chemicals company Monsanto is facing a surge in lawsuits that may cost its new owners, Bayer, billions in damages. Monsanto manufactures glyphosate-based weed killers which some believe are carcinogenic. Last month it lost a US$ 289m court case that alleged its products Roundup and RangerPro had led to a Californian man's terminal cancer.

  • Monday, June 4th 2018 - 08:42 UTC

    New blood test could detect different types of cancer even in early stages

    “This is a very promising study,” said Dr. Kazuaki Takabe, the Alfiero Foundation in breast oncology at the Roswell Park Comprehensive Cancer Center in Buffalo

    A new blood test shows promise for detecting many types of cancer, even in the early stages of the disease, according to a new study. In the study, researchers found that the test could detect 10 types of cancer and that it was 80 to 90% accurate for some cancer types. However, much more research is needed before doctors will be able to use the test on their patients, experts say.

  • Thursday, January 18th 2018 - 09:21 UTC

    Advanced research shows how cancer cells interfere with DNA genetic instructions

    The team at the Institute of Cancer Research used a technique called cryo-electron microscopy, which won the 2017 Nobel Prize for Chemistry

    “Incredible” images of DNA in action have been captured by scientists who will use them to design cancer drugs. Researcher Dr Alessandro Vannini said the pictures were “beautiful” and in artistic comparisons were “definitely a Van Gogh”, since they capture a fundamental part of all plant and animal life, called RNA polymerase III, reading the genetic instructions contained in DNA. It is a process that gets hijacked by cancer.

  • Wednesday, January 3rd 2018 - 09:52 UTC

    AI system beats cardiologists and oncologists in detecting heart diseases and lung cancer

    Another AI system is looking for signs of lung cancer. It searches for large clumps of cells called nodules.

    Researchers at an Oxford hospital have developed artificial intelligence (AI) that can diagnose scans for heart disease and lung cancer. The systems will save billions of pounds by enabling the diseases to be picked up much earlier. The heart disease technology will start to be available to NHS hospitals for free this summer.

  • Monday, January 4th 2016 - 09:27 UTC

    Lifestyles have a greater impact on cancer suggest latest findings; likewise they might be more preventable

    It was previously thought that fewer than half of cancer could be prevented by lifestyle changes, but the new research indicates that it could be much higher.

    Earlier this year, researchers sparked a debate by suggesting that random cell mutations, rather than lifestyle choices, played a significant role in the development of tumors, a finding dubbed the “bad luck hypothesis.” A new study has nevertheless led scientists to believe that external influences have a far greater impact, implying that many cancers may be more preventable than previously thought.

  • Sunday, January 4th 2015 - 06:39 UTC

    Most types of cancer traced to 'bad luck' rather than risk factors, say scientists

    In the US, 6.9% of people develop lung cancer, 0.6% brain cancer and 0.00072% get tumors in their laryngeal cartilage at some point in their lifetime.

    Most types of cancer can be put down to bad luck rather than risk factors such as smoking, a study has suggested. US teams were trying to explain why some tissues were millions of times more vulnerable to cancer than others.

  • Monday, August 11th 2014 - 01:24 UTC

    A simple old remedy to help reduce the risk of developing some cancers

    Trials and studies has revealed that long-term use of low-dose aspirin reduces the risk of developing major cancers and dying from them by around one-third.

    In what is being viewed as one of the most important discoveries in the battle against cancer, a major review of trials and studies has revealed that long-term use of low-dose aspirin reduces the risk of developing major cancers and dying from them by around one-third.